Cervical Cancer

Report card on cervical cancer prevention underscores importance of HPV testing

Published in Medical Letter on the CDC and FDA, February 20th, 2005

According to a new report, top performing states in cervical cancer prevention all reimburse for U.S. Food and Drug Administration-approved human papillomavirus (HPV) testing for routine screening through their Medicaid programs.

The recognition of HPV testing as an indicator of success in the Women In Government report, "A Call to Action: the 'State' of Cervical Cancer Prevention in America," underscores the test's growing importance from a public health perspective.

"Our report shows that states that are the most successful have higher screening rates, cover advanced screening technology - particularly HPV testing - in their public insurance...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2005-02-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry